David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,000 shares at $56.90 ($285K) on 2015-01-12, disclosed to the SEC on 2015-01-14.
Scheduled sale ($284k) by EVP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |
| CPHD | SELL | 2014-10-31 | $1.1M | — | Filing → |